Related Experiment Video
Updated: Jun 20, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications
Giuseppe Marano1, Desiree Harnic, Marzia Lotrionte
1Department of Neuroscience, Institute of Psychiatry and Psychology, Catholic University of Sacred Heart, Rome, Italy.
Insights
This review examines the link between depression and cardiovascular disease, highlighting biobehavioral mechanisms. Selective serotonin reuptake inhibitors are recommended for treating depressed cardiac patients due to their safety profile.
Area of Science:
- Cardiovascular Medicine
- Psychiatry
- Epidemiology
Background:
- Depression is a significant risk factor for cardiovascular disease (CVD).
- Understanding the mechanistic links between depression and CVD is crucial for improving patient outcomes.
- Biobehavioral factors play a key role in the depression-cardiovascular disease relationship.
Purpose of the Study:
- To review epidemiological evidence on the relationship between depression and cardiovascular disease.
- To explore the biological, behavioral, and social mechanisms underlying this association.
- To provide evidence-based recommendations for pharmacotherapy in patients with comorbid depression and CVD.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of mechanistic pathways linking depression and cardiovascular disease.
- Evaluation of antidepressant effects on the cardiovascular system.
Main Results:
- Plausible biobehavioral mechanisms connecting depression and cardiovascular disease have been identified.
- Tricyclic antidepressants (TCAs) can have adverse cardiovascular effects.
- Selective serotonin reuptake inhibitors (SSRIs) show no significant adverse cardiac effects.
Conclusions:
- SSRIs are the preferred pharmacotherapy for patients with comorbid depression and cardiovascular disease.
- Further research into biobehavioral mechanisms can optimize treatment strategies.
- Integrated care approaches are essential for managing depressed cardiac patients.
Abstract:
This review explores the epidemiological evidence for the relationship between depression and cardiovascular disease from a mechanistic standpoint. It is important to examine the biological, behavioral and social mechanisms to improve outcomes for depressed cardiac patients. A number of plausible biobehavioral mechanisms linking depression and cardiovascular disease have been identified. Tricyclic antidepressants have various effects on the cardiovascular system, while selective serotonin reuptake inhibitors are not associated with adverse cardiac effects and should, therefore, be the preferred choice for the treatment of most patients with comorbid depression and cardiovascular disease.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Hypertension II: Pathophysiology
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
